Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Hodgkin Disease

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Hodgkin Disease in 2 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dutton, A1
Reynolds, GM1
Dawson, CW1
Young, LS1
Murray, PG1
Georgakis, GV1
Li, Y1
Rassidakis, GZ1
Medeiros, LJ1
Mills, GB1
Younes, A1

Other Studies

2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Hodgkin Disease

ArticleYear
Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTOR.
    The Journal of pathology, 2005, Volume: 205, Issue:4

    Topics: Adaptor Proteins, Signal Transducing; Antibiotics, Antineoplastic; Carrier Proteins; Cell Cycle Prot

2005
Inhibition of the phosphatidylinositol-3 kinase/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma.
    British journal of haematology, 2006, Volume: 132, Issue:4

    Topics: Antigens, CD; Apoptosis; Carrier Proteins; Caspase 9; Caspases; CD30 Ligand; CD40 Ligand; Cell Line,

2006